Our high-throughput QPatch II automated patch clamp instrument enabled Linköping University to accelerate its research into a new epilepsy drug – and get the green light to build a national core facility for ion channel research.

Linköping University’s Division of Neurobiology immediately saw the full potential of its new QPatch II patch clamp instrument. The team had been accustomed to testing one compound on one ion channel per day using conventional manual equipment in their electrophysiology laboratory. The arrival of the automated QPatch II from Sophion Bioscience changed that at a stroke.

For Linköping University, the focus now is on using the QPatch II to make further progress towards a drug for epilepsy. At the same time, the team has high hopes for their new core facility to attract clinicians, electrophysicists, and pharmacologists from all over Sweden, who want to expand their range of automated patch clamp experiments.